Retrospective analysis of sorafenib as first or second target therapy in mRCC patients in Italian centers: An update.

e15524 Background: With several agents available for the treatment of metastatic renal cell carcinoma (mRCC) a better understanding of their use in daily clinical practice is fundamental in the dec...